We are The Intelligence MachineTM

Using Artificial Intelligence to cut drug development time, from synthesis to approval, significantly.

We help organizations move to continuous decision making by generating insights from structured and unstructured private and public data

Innoplexus proudly announces the launch of its product iPlexusTM, at Bio-IT World, 2017,Booth #355.It is an end to end platform for Life Sciences which leverages Artificial Intelligence(AI) to generate continuous intelligence and insights, across discovery, clinical development, regulatory and commercial stages of drug development, spanning all major therapeutic areas and indications.

We’re disrupting traditional processes & fundamentally transforming how intelligence and analytics is generated and consumed in enterprises by making data and insights available everywhere, every time.

What problem are we solving at Innoplexus ?

In many organizations, Decision making is still a batch process.

Data – Requires human effort and is expensive

Insights – Lack context and are obvious

data & Insights – Not available everywhere, everytime

Traditional processes of analyzing and providing data

Traditionally, both generation and consumption of intelligence and insights in enterprises remain predominantly manual.

Manually curated & analyzed data in presentations, lack real-time insights and are not comprehensive, rendering decision making a batch process.

Our proprietary technology enables full scale automation for intelligence in industries.

We’re helping organizations move to continuous decision making by generating insights from structured and unstructured private and public data by using proprietary algorithms, machine learning & AI.

Read more

From the Blog

page 1 of 4